Stock Chart IconStock chart iconBillionToOne's year-to-date stock performance. BillionToOne: "We decided it's a pretty darn good company. ... I think you have a good one."Stock Chart IconStock chart iconEton Pharmaceuticals' year-to-date stock performance. Eton Pharmaceuticals: "It's a biotech that's been a winner. I like to take a little bit off of the biotech winner and then let the rest run."Stock Chart IconStock chart iconBabcock & Wilcox's year-to-date stock performance. Stock Chart IconStock chart iconSmithfield Foods' year-to-date stock performance. Smithfield Foods: "You know, it's a very inexpensive stock. ... I am willing to bet that at 8 times earnings you're not going to lose money, and you could make some money with a 5.6% yield."Stock Chart IconStock chart iconQXO's year-to-date stock performance. QXO: "First of all, I think you should buy it. He's putting together a conglomerate for building products, mostly roofing, at a time when people hate building products, but what happens when the Fed finally has to cut rates because housing's so bad, which I think can happen? Well, I'll tell you what happens: that stock goes from $14 to $24. That's why I think you should own it."Stock Chart IconStock chart iconIES Holdings' year-to-date stock performance. IES Holdings: "This is a very interesting data communications company that has been brought down. I don't think that makes sense. I think you have a good one."